CV SCIENCES, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0518 USD | +3.84% |
|
+4.86% | +46.33% |
| May. 14 | Transcript : CV Sciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
| May. 14 | CV Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presentation Operator MessageOperator (Operator)Greetings. Welcome to the CV Sciences First Qu...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
CV Sciences, Inc. is a consumer wellness company specializing in nutraceuticals and plant-based foods. Its hemp extracts, and other science-backed, natural ingredients and products are sold through a range of sales channels from business-to-business to business-to-consumer. It operates a drug development program focused on developing and commercializing cannabidiol (CBD)-based therapeutics. It develops, manufactures, markets and sells herbal supplements, CBD products and plant-based food products under brands: +PlusCBD and Cultured Foods in the healthcare market sector: nutraceutical, beauty care, specialty foods, and pet products. +PlusCBD branded products are sold at select retail locations throughout the United States. Cultured Foods brand provides a variety of plant-based food products and caters to individuals seeking vegan, gluten-free, or flexitarian options for a culinary experience. It manufactures encapsulated softgels and tinctures for the supplement and nutrition industry.
Sector
Pharmaceuticals
Calendar
2024-06-03
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| +46.33% | 8.15M | |
| +32.95% | 709B | |
| +30.77% | 595B | |
| -1.87% | 367B | |
| +20.23% | 334B | |
| +5.91% | 289B | |
| +14.77% | 239B | |
| +9.13% | 211B | |
| -3.97% | 203B | |
| +8.92% | 171B |
- Stock Market
- Equities
- CVSI Stock
- News CV Sciences, Inc.
- Transcript : CV Sciences, Inc., Q1 2022 Earnings Call, May 16, 2022